Overview

Pilot Study of Varenicline to Treat Opioid Dependence

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The objective of this proposal is to explore the potential of varenicline as a pharmacotherapeutic agent for opioid dependence and addiction.
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Analgesics, Opioid
Varenicline